Till startsida
To content Read more about how we use cookies on gu.se

Wallenberg Centre yearly event 2019


Where: Wallenbergsalen, Conference Centre Wallenberg, Medicinaregatan 20A, Gothenburg
When: January 31, 12.00-17.00 (including lunchwrap and coffee break)

Listen to our recently recruited Wallenberg Centre researchers and invited speakers from AstraZeneca and University of Gothenburg, and mingle with all speakers and fellows and other members from Wallenberg Centres for Molecular Medicine (WCMMs) and SciLife Lab.

On the theme "FROM IDEA TO TARGET" invited speakers will guide you through their research experiences in industry and academia:

GUNILLA WESTERGREN-THORSSON, director WCMM at Lund University, will give a short introduction and her perspectives on the national Wallenberg Centre effort.

PERNILLE LAERKEGAARD HANSEN, professor and head of department of Chronic Kidney Disease at IMED CVRM AstraZeneca, will give the talk ”We begin with the end”.

HENRIC OLSSON, head of Target Science IMED RIA AstraZeneca will share his experiences from drug development.

BO SÖDERPALM, professor at the Institute of Neuroscience and physiology and senior consultant at the Sahlgrenska University Hospital, who has been awarded a Swedish Research Council “Proof of Concept” grant, will present his research "Exploiting brain dopamine systems for treatment of alcohol use disorder“.

Newly recruited WCMTM fellows will present their research:

Anetta Svitorka Härtlova has been recruited from the Newcastle University, UK, to the Institute of Biomedicine, and her main research focus is on understanding the role and regulation of immune and inflammatory pathways in the context of ageing and age-related pathologies.
She will give a talk titled "Understanding molecular mechanisms of innate immunity in age-related pathologies"

Alesia Tietze has been recruited from the University of Technology in Darmstadt, Germany, to the Institute of Chemistry and Molecular Biology. Alesia's research interest lies in the area of medicinal chemistry with focus on the development of protease-stable peptide analogs derived from bioactive peptides.
The title of her talk is"Chemical synthesis of bioactive peptides & membrane-associated proteins: from drug discovery to bioinspired materials”

Volkan Sayin has been recruited from the New York University School of Medicine, USA, to the Institute of Clinical Sciences. Volkan’s research is focusing on uncovering genotype dependent therapeutic vulnerabilities in lung cancer and he has a longstanding interest in redox biology, metabolism and the role of antioxidants in tumor development.
Volkan will talk about “Targeting metabolic dependencies in subtypes of lung cancer”

ROGER OLOFSSON BAGGE and MARTIN DALIN, our newest clinical recruitments to Wallenberg Centre, will present their clinical research programs within the area of cancer entitled ”Clinical trials in melanoma as a source for translational research”and "Circulating tumor DNA in pediatric cancer”, respectively.

A more detailed program will be published shortly.

For questions email research coordinator Julia Grönros julia.gronros@gu.se


Warm welcome,
Director WCMTM, professor Christina Jern



Page Manager: Mattias Lindgren|Last update: 12/8/2018

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?

Denna text är utskriven från följande webbsida:
Utskriftsdatum: 2019-01-22